What is Xarelto?
Xarelto is a direct factor Xa inhibitor drug that was originally approved in 2011 by the U.S. Food and Drug Administration as a preventative measure for people with atrial fibrillation. During the three years since the FDA first approved Xarelto for the open market, there have been over 1,800 adverse medical events linked to its use. These adverse events have included:
- Bleeding ulcers
- Internal bleeding
- Severe or uncontrolled bleeding events
Dangers and Symptoms
There are two main potentially life-threatening factors that have been associated with taking Xarelto. The first is that the drug manufacturers may not be properly sharing the potentially serious health risks when they market it as a lifestyle friendly drug that does not require regular follow-up doctor visits and blood monitoring.Secondly, once a severe internal bleeding episode begins, doctors do not have an antidote to easily reverse the severe side effects. Due to the relaxed blood monitoring and office visits, the potential health risks of Xarelto are even higher among patients with poor kidney function.